cyclosporine and Bradyarrhythmia

cyclosporine has been researched along with Bradyarrhythmia in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (80.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hansen, PB; Jensen, BL; Khatam-Lashgari, A; Stæhr, M; Vanhoutte, PM1
Fujisaki, G; Inokuchi, C; Kami, M; Kishi, Y; Momomura, S; Murashige, N; Tanosaki, R1
Enosawa, S; Fukuchi, K; Hakamata, Y; Iwanami, S; Kaneko, T; Kishi, T; Kobayashi, E; Kudou, S; Kuriyama, K; Matsumoto, K; Morishita, Y; Murakami, T; Shimizu, H; Takahashi, M; Takeyoshi, I; Yasue, T1
Cremer, M; Hmissi, A; Lang, P; Mayer, H; Schena, FP; Shoker, A; Sommerer, C; Szakaly, P; Tedesco-Silva, H; Yoshimura, N1
Davis, WR; Kelleher, SP; Paraskevopoulos, N1

Trials

1 trial(s) available for cyclosporine and Bradyarrhythmia

ArticleYear
FTY720 versus mycophenolate mofetil in de novo renal transplantation: six-month results of a double-blind study.
    Transplantation, 2007, Oct-15, Volume: 84, Issue:7

    Topics: Adult; Biopsy; Bradycardia; Cohort Studies; Cyclosporine; Double-Blind Method; Female; Fingolimod Hydrochloride; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Mycophenolic Acid; Propylene Glycols; Receptors, Lysosphingolipid; Sphingosine

2007

Other Studies

4 other study(ies) available for cyclosporine and Bradyarrhythmia

ArticleYear
The calcineurin inhibitor cyclosporine A improves lipopolysaccharide-induced vascular dysfunction but does not rescue from cardiovascular collapse in endotoxemic mice.
    Pflugers Archiv : European journal of physiology, 2013, Volume: 465, Issue:10

    Topics: Animals; Aorta; Blood Pressure; Bradycardia; Calcineurin Inhibitors; Cyclosporine; Endotoxemia; Heart Rate; Hypotension; Injections, Intravenous; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Nitric Oxide; Nitric Oxide Synthase Type II; Phenylephrine; Vasoconstriction

2013
Sinus bradycardia associated with cyclosporine following allogeneic hematopoietic stem cell transplantation.
    Bone marrow transplantation, 2005, Volume: 35, Issue:2

    Topics: Adult; Bradycardia; Cyclosporine; Hematopoietic Stem Cell Transplantation; Humans; Male; Myelodysplastic Syndromes; Transplantation, Homologous

2005
KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts.
    Circulation, 2005, Jan-18, Volume: 111, Issue:2

    Topics: Animals; Bradycardia; Chemotaxis, Leukocyte; Chronic Disease; Cyclosporine; Drug Evaluation, Preclinical; Drug Therapy, Combination; Fingolimod Hydrochloride; Graft Rejection; Graft Survival; Guinea Pigs; Heart Rate; Heart Transplantation; Immunosuppressive Agents; Male; Molecular Structure; Propylene Glycols; Rats; Rats, Inbred F344; Rats, Inbred Lew; Rats, Inbred Strains; Rats, Wistar; Skin Transplantation; Sphingosine; Sulfhydryl Compounds; Transplantation, Heterotopic; Transplantation, Homologous

2005
Gout, bradycardia, and hypercholesterolemia after renal transplantation.
    Southern medical journal, 2001, Volume: 94, Issue:7

    Topics: Bradycardia; Colchicine; Cyclosporine; Drug Interactions; Female; Gout; Gout Suppressants; Humans; Hypercholesterolemia; Immunosuppressive Agents; Kidney Transplantation; Middle Aged; Postoperative Complications

2001